<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2020-26-1-53-63</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-1832</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Предикторы повышения артериального давления у женщин после индукции суперовуляции при экстракорпоральном оплодотворении</article-title><trans-title-group xml:lang="en"><trans-title>Predictors of increased blood pressure in women after induction of superovulation for extracorporeal fertilization</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1393-5003</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вакарева</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vakareva</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вакарева Виктория Викторовна — аспирант кафедры семейной медицины факультета послевузовского и дополнительного профессионального образования</p><p>ул. Литовская, д. 2, Санкт-Петербург, 194100</p></bio><bio xml:lang="en"><p>Victoria V. Vakareva, MD, Postgraduate Student, Department of Family Medicine</p><p>2 Litovskaya street, St Petersburg, 194100</p></bio><email xlink:type="simple">barbora83@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4334-5434</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Авдеева</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Avdeeva</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Авдеева Марина Владимировна — доктор медицинских наук, профессор кафедры семейной медицины факультета послевузовского и дополнительного профессионального образования ФГБОУ ВО «СПбГПМУ» Минздрава России; профессор кафедры общественного здоровья, экономики и управления здравоохранением ФГБОУ ВО «СЗГМУ им. И. И. Мечникова» Минздрава России</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Marina V. Avdeeva, MD, PhD, DSc, Professor, Department of Family Medicine; Professor, Department of Public Health, Economics and Health Management</p><p>St Petersburg</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щеглова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Scheglova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Щеглова Лариса Васильевна — доктор медицинских наук, профессор, заведующая кафедрой семейной медицины факультета послевузовского и дополнительного профессионального образования</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Larisa V. Shcheglova, MD, PhD, DSc, Professor, Head, Department of Family Medicine</p><p>St Petersburg</p></bio><email xlink:type="simple">shcheglovalar@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Санкт-Петербургский государственный педиатрический медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>St. Petersburg State Pediatric Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Санкт-Петербургский государственный педиатрический медицинский университет» Министерства здравоохранения Российской Федерации; Федеральное государственное бюджетное образовательное учреждение высшего образования «Северо-Западный государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>St. Petersburg State Pediatric Medical University; North-Western State Medical University named after I. I. Mechnikov</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>29</day><month>01</month><year>2020</year></pub-date><volume>26</volume><issue>1</issue><fpage>53</fpage><lpage>63</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Вакарева В.В., Авдеева М.В., Щеглова Л.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Вакарева В.В., Авдеева М.В., Щеглова Л.В.</copyright-holder><copyright-holder xml:lang="en">Vakareva V.V., Avdeeva M.V., Scheglova L.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/1832">https://htn.almazovcentre.ru/jour/article/view/1832</self-uri><abstract><p>Цель исследования — изучить взаимосвязь гемодинамических, гормональных и метаболических изменений с повышением артериального давления (АД) у женщин после индукции суперовуляции при экстракорпоральном оплодотворении (ЭКО).</p><sec><title>Материалы и методы</title><p>Материалы и методы. Обследовано 80 женщин в возрасте от 25 до 38 лет (средний возраст 32,3 ± 3,6 года). Все пациентки проходили ЭКО в центре репродуктивных технологий СПб ГБУЗ «Городская Мариинская больница». Суточное мониторирование АД проводилось дважды: перед индукцией суперовуляции при ЭКО и в первые сутки после данной манипуляции.</p></sec><sec><title>Результаты</title><p>Результаты. После индукции суперовуляции у 52,5 % женщин произошло повышение среднедневного АД ≥ 135/85 мм рт. ст., а у 13,8 % — повышение средненочного АД ≥ 120/70 мм рт. ст. У женщин с исходно повышенным среднедневным АД относительный риск его дальнейшего повышения в первые сутки после индукции суперовуляции составил 1,46 (95-процентный доверительный интервал (95 % ДИ) 0,79–2,68) по сравнению с женщинами, имевшими нормальный профиль среднедневного АД. У женщин с исходно повышенным средненочным АД относительный риск его дальнейшего подъема после индукции суперовуляции составил 1,16 (95 % ДИ 1,06–1,27). Повышение уровня АД после индукции суперовуляции может быть связано с возрастом, женским фактором бесплодия, наличием в анамнезе хронических заболеваний мочеполовой системы, изменением метаболического профиля (повышение уровня общего холестерина, мочевины, креатинина, глюкозы, эстрадиола, снижение уровня тиреотропного гормона), нарушениями сердечного ритма, эпизодами апноэ/гипопноэ во сне, повышением частоты сердечных сокращений, усилением активности симпатического отдела вегетативной нервной системы.</p></sec><sec><title>Заключение</title><p>Заключение. В связи с неблагоприятным влиянием индукции суперовуляции на суточный профиль АД в период планирования экстракорпорального оплодотворения необходимо выявлять и модифицировать факторы риска повышения АД. Это позволит заблаговременно подготовить женщину к предстоящей процедуре и избежать неблагоприятных реакций со стороны сердечно-сосудистой системы. Женщины с гипертензивной реакцией, наблюдавшейся после индукции суперовуляции, нуждаются в динамическом контроле АД для определения терапевтической тактики.</p></sec></abstract><trans-abstract xml:lang="en"><p>Objective is to study the relationship of hemodynamic, hormonal and metabolic changes with increased blood pressure (BP) in women after the induction of superovulation for extracorporeal fertilization (ECF).</p><sec><title>Design and methods</title><p>Design and methods. We examined 80 women aged from 25 to 38 years (mean age 32,3 ± 3,6 years). All patients underwent ECF at the Center for Reproductive Technologies of the St Petersburg Mariinsky Hospital. Daily monitoring of BP was carried out twice: before the induction of superovulation for ECF and on the first day after this manipulation.</p></sec><sec><title>Results</title><p>Results. After induction of superovulation, an increase in average daily BP ≥ 135/85 mm Hg occurred in 52,5 % of women and an increase in average night BP ≥ 120/70 mm Hg was registered in 13,8 %. In women with initially increased average daily BP, the relative risk of its further increase on the first day after induction of superovulation was 1,46 (95 % confidence interval (CI) 0,79–2,68) compared with women who had normal average daily BP. In women with initially elevated average nightly BP, the relative risk of its further increase after induction of superovulation was 1,16 (95 % CI 1,06–1,27). An increase of BP after induction of superovulation may be associated with age, female factor infertility, the presence of chronic diseases of the genitourinary system in past, changes in the metabolic profile (increase in total cholesterol, urea, creatinine, glucose, estradiol; decreased thyroid-stimulating hormone level), heart rhythm disturbances, episodes of apnea/hypopnea during sleep, increase in heart rate, increased sympathetic activity.</p></sec><sec><title>Conclusions</title><p>Conclusions. Induction of superovulation during in vitro fertilization has an adverse effect on the circadian BP profile. While planning in vitro fertilization, the risk factors for BP increase should be identified and modified. This will help to avoid adverse cardiovascular reactions associated with the procedure. Women with the hypertensive reaction after the induction of superovulation require dynamic BP monitoring.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>здоровье женщин</kwd><kwd>артериальная гипертензия</kwd><kwd>индукция суперовуляции</kwd><kwd>экстракорпоральное оплодотворение</kwd><kwd>артериальная гипертензия у женщин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>women’s health</kwd><kwd>hypertension</kwd><kwd>induction of superovulation</kwd><kwd>extracorporeal fertilization</kwd><kwd>arterial hypertension in women</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Asemota OA, Klatsky P. Access to infertility care in the developing world: the family promotion gap. Semin Reprod Med. 2015;33(1):17–22.</mixed-citation><mixed-citation xml:lang="en">Asemota OA, Klatsky P. Access to infertility care in the developing world: the family promotion gap. Semin Reprod Med. 2015;33(1):17–22.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Farquhar C, Rishworth JR, Brown J, Nelen WL, Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2015;7: doi:10.1002/14651858.CD010537.pub4</mixed-citation><mixed-citation xml:lang="en">Farquhar C, Rishworth JR, Brown J, Nelen WL, Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2015;7: doi:10.1002/14651858.CD010537.pub4</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Русанова Н. Е. Вспомогательные репродуктивные технологии в России: история, проблемы, демографические перспективы. Журнал исследований социальной политики. 2013;1:69–85.</mixed-citation><mixed-citation xml:lang="en">Rusanova NE. Assisted reproductive technologies in Russia: history, problems, demographic prospects. Zhurnal Issledovanij Sotsial’noj Politiki = J Soc Policy Studies. 2013;1:69–85. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Park K, Wei J, Minissian M, Bairey Merz CN, Pepine CJ. Adverse pregnancy conditions, infertility, and future cardiovascular risk: implications for mother and child. Cardiovasc Drugs Ther. 2015;29(4);391–401.</mixed-citation><mixed-citation xml:lang="en">Rusanova NE. Assisted reproductive technologies in Russia: history, problems, demographic prospects. Zhurnal Issledovanij Sotsial’noj Politiki = J Soc Policy Studies. 2013;1:69–85. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Балабан И. В., Пятибрат Е. Д., Прошин С. Н., Цикунов С. Г., Шабанов П. Д. Механизм нарушения фертильности у женщин-военнослужащих в экстремальных условиях локальных конфликтов и патогенетические методы их коррекции. Педиатр. 2015;6(4):39–44.</mixed-citation><mixed-citation xml:lang="en">Park K, Wei J, Minissian M, Bairey Merz CN, Pepine CJ. Adverse pregnancy conditions, infertility, and future cardiovascular risk: implications for mother and child. Cardiovasc Drugs Ther. 2015;29(4);391–401.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mahalingaiah S, Sun F, Cheng JJ, Chow ET, Lunetta KL, Murabito JM. Cardiovascular risk factors among women with self-reported infertility. Fertil Res Pract. 2017;3:7. doi:10.1186/s40738-017-0034-0</mixed-citation><mixed-citation xml:lang="en">Park K, Wei J, Minissian M, Bairey Merz CN, Pepine CJ. Adverse pregnancy conditions, infertility, and future cardiovascular risk: implications for mother and child. Cardiovasc Drugs Ther. 2015;29(4);391–401.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rossberg N, Stangl K, Stangl V. Pregnancy and cardiovascular risk: a review focused on women with heart disease undergoing fertility treatment. Eur J Prev Cardiol. 2016;23(18):1953–1961.</mixed-citation><mixed-citation xml:lang="en">Balaban IV, Pyatibrat ED, Proshin SN, Tsikunov SG, Shabanov PD. The mechanism of fertility impairment in female military personnel in the extreme conditions of local conflicts and pathogenetic methods for their correction. Pediatr = Pediatrician. 2015;6(4):39–44. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Thomopoulos C, Tsioufis C, Michalopoulou H, Makris T, Papademetriou V, Stefanadis C. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. J Hum Hypertens. 2013;27(3):148–157.</mixed-citation><mixed-citation xml:lang="en">Balaban IV, Pyatibrat ED, Proshin SN, Tsikunov SG, Shabanov PD. The mechanism of fertility impairment in female military personnel in the extreme conditions of local conflicts and pathogenetic methods for their correction. Pediatr = Pediatrician. 2015;6(4):39–44. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Opdahl S, Henningsen AA, Tiitinen A, Bergh C, Pinborg A, Romundstad PR et al. Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod. 2015;30(7):1724–1731. doi:10.1093/humrep/dev090</mixed-citation><mixed-citation xml:lang="en">Mahalingaiah S, Sun F, Cheng JJ, Chow ET, Lunetta KL, Murabito JM. Cardiovascular risk factors among women with self-reported infertility. Fertil Res Pract. 2017;3:7. doi:10.1186/s40738-017-0034-0</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Toshimitsu M, Nagamatsu T, Nagasaka T, Iwasawa-Kawai Y, Komatsu A, Yamashita T et al. Increased risk of pregnancy-induced hypertension and operative delivery after conception-induced by in vitro fertilization/intracytoplasmic sperm injection in women aged 40 years and older. Fertil Steril. 2014;102(4):1065–1070.</mixed-citation><mixed-citation xml:lang="en">Mahalingaiah S, Sun F, Cheng JJ, Chow ET, Lunetta KL, Murabito JM. Cardiovascular risk factors among women with self-reported infertility. Fertil Res Pract. 2017;3:7. doi:10.1186/s40738-017-0034-0</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lamminpää R, Vehviläinen-Julkunen K, Gissler M, Heinonen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997–2008. BMC Pregnancy Childbirth. 2012;12:47. doi:10.1186/1471-2393-12-47</mixed-citation><mixed-citation xml:lang="en">Rossberg N, Stangl K, Stangl V. Pregnancy and cardiovascular risk: a review focused on women with heart disease undergoing fertility treatment. Eur J Prev Cardiol. 2016;23(18):1953–1961.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: A meta-analysis of cohort studies. Fertil Steril. 2016;105(1):73–85.</mixed-citation><mixed-citation xml:lang="en">Rossberg N, Stangl K, Stangl V. Pregnancy and cardiovascular risk: a review focused on women with heart disease undergoing fertility treatment. Eur J Prev Cardiol. 2016;23(18):1953–1961.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dayan N, Filion KB, Okano M, Kilmartin C, Reinblatt S, Landry T et al. Cardiovascular risk following fertility therapy: systematic review and meta-analysis. J Am Coll Cardiol. 2017;70(10):1203–1213. doi:10.1016/j.jacc.2017.07.753</mixed-citation><mixed-citation xml:lang="en">Thomopoulos C, Tsioufis C, Michalopoulou H, Makris T, Papademetriou V, Stefanadis C. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. J Hum Hypertens. 2013;27(3):148–157.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Udell JA, Lu H, Redelmeier DA. Long-term cardiovascular risk in women prescribed fertility therapy. J Am Coll Cardiol. 2013;62(18):1704–1712.</mixed-citation><mixed-citation xml:lang="en">Thomopoulos C, Tsioufis C, Michalopoulou H, Makris T, Papademetriou V, Stefanadis C. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. J Hum Hypertens. 2013;27(3):148–157.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Udell JA, Lu H, Redelmeier DA. Failure of fertility therapy and subsequent adverse cardiovascular events. Can Med Assoc J. 2017;189(10):391–397. doi:10.1503/cmaj.160744</mixed-citation><mixed-citation xml:lang="en">Opdahl S, Henningsen AA, Tiitinen A, Bergh C, Pinborg A, Romundstad PR et al. Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod. 2015;30(7):1724–1731. doi:10.1093/humrep/dev090</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Рогоза А. Н., Никольский В. П., Ощепкова Е. В. Суточное мониторирование артериального давления при гипертонии. Методические вопросы. Под редакцией Г. Г. Арабидзе и О. Ю. Атькова. М.: Российский кардиологический научно-производственный комплекс МЗ РФ, 2005. 36 с.</mixed-citation><mixed-citation xml:lang="en">Opdahl S, Henningsen AA, Tiitinen A, Bergh C, Pinborg A, Romundstad PR et al. Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod. 2015;30(7):1724–1731. doi:10.1093/humrep/dev090</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Рекомендации по лечению больных с артериальной гипертензией Европейского общества кардиологов и Европейского общества по артериальной гипертензии. Российский кардиологический журнал. 2018;23(12):143–228</mixed-citation><mixed-citation xml:lang="en">Toshimitsu M, Nagamatsu T, Nagasaka T, Iwasawa-Kawai Y, Komatsu A, Yamashita T et al. Increased risk of pregnancy-induced hypertension and operative delivery after conception-induced by in vitro fertilization/intracytoplasmic sperm injection in women aged 40 years and older. Fertil Steril. 2014;102(4):1065–1070.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Imudia AN, Awonuga AO, Doyle JO, Kaimal AJ, Wright DL, Toth TL et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril. 2012;97(6):1374–1379.</mixed-citation><mixed-citation xml:lang="en">Toshimitsu M, Nagamatsu T, Nagasaka T, Iwasawa-Kawai Y, Komatsu A, Yamashita T et al. Increased risk of pregnancy-induced hypertension and operative delivery after conception-induced by in vitro fertilization/intracytoplasmic sperm injection in women aged 40 years and older. Fertil Steril. 2014;102(4):1065–1070.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Sun X, Zang L, Zhang Q, Li J, Zou S. Correlation between steroid hormonal levels and cardiac function in women during controlled ovarian hyperstimulation. Endocrine. 2013;44(3):784–789.</mixed-citation><mixed-citation xml:lang="en">Lamminpää R, Vehviläinen-Julkunen K, Gissler M, Heinonen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997–2008. BMC Pregnancy Childbirth. 2012;12:47. doi:10.1186/1471-2393-12-47</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002;53(3):688–708.</mixed-citation><mixed-citation xml:lang="en">Lamminpää R, Vehviläinen-Julkunen K, Gissler M, Heinonen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997–2008. BMC Pregnancy Childbirth. 2012;12:47. doi:10.1186/1471-2393-12-47</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sealey JE, Itskovitz-Eldor J, Rubattu S, James GD, August. Estradiol and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab. 1994;79(1):258–264.</mixed-citation><mixed-citation xml:lang="en">Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: A meta-analysis of cohort studies. Fertil Steril. 2016;105(1):73–85.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: A meta-analysis of cohort studies. Fertil Steril. 2016;105(1):73–85.</mixed-citation><mixed-citation xml:lang="en">Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: A meta-analysis of cohort studies. Fertil Steril. 2016;105(1):73–85.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Dayan N, Filion KB, Okano M, Kilmartin C, Reinblatt S, Landry T et al. Cardiovascular risk following fertility therapy: systematic review and meta-analysis. J Am Coll Cardiol. 2017;70(10):1203–1213. doi:10.1016/j.jacc.2017.07.753</mixed-citation><mixed-citation xml:lang="en">Dayan N, Filion KB, Okano M, Kilmartin C, Reinblatt S, Landry T et al. Cardiovascular risk following fertility therapy: systematic review and meta-analysis. J Am Coll Cardiol. 2017;70(10):1203–1213. doi:10.1016/j.jacc.2017.07.753</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Dayan N, Filion KB, Okano M, Kilmartin C, Reinblatt S, Landry T et al. Cardiovascular risk following fertility therapy: systematic review and meta-analysis. J Am Coll Cardiol. 2017;70(10):1203–1213. doi:10.1016/j.jacc.2017.07.753</mixed-citation><mixed-citation xml:lang="en">Dayan N, Filion KB, Okano M, Kilmartin C, Reinblatt S, Landry T et al. Cardiovascular risk following fertility therapy: systematic review and meta-analysis. J Am Coll Cardiol. 2017;70(10):1203–1213. doi:10.1016/j.jacc.2017.07.753</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Udell JA, Lu H, Redelmeier DA. Long-term cardiovascular risk in women prescribed fertility therapy. J Am Coll Cardiol. 2013;62(18):1704–1712.</mixed-citation><mixed-citation xml:lang="en">Udell JA, Lu H, Redelmeier DA. Long-term cardiovascular risk in women prescribed fertility therapy. J Am Coll Cardiol. 2013;62(18):1704–1712.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Udell JA, Lu H, Redelmeier DA. Long-term cardiovascular risk in women prescribed fertility therapy. J Am Coll Cardiol. 2013;62(18):1704–1712.</mixed-citation><mixed-citation xml:lang="en">Udell JA, Lu H, Redelmeier DA. Long-term cardiovascular risk in women prescribed fertility therapy. J Am Coll Cardiol. 2013;62(18):1704–1712.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Udell JA, Lu H, Redelmeier DA. Failure of fertility therapy and subsequent adverse cardiovascular events. Can Med Assoc J. 2017;189(10):391–397. doi:10.1503/cmaj.160744</mixed-citation><mixed-citation xml:lang="en">Udell JA, Lu H, Redelmeier DA. Failure of fertility therapy and subsequent adverse cardiovascular events. Can Med Assoc J. 2017;189(10):391–397. doi:10.1503/cmaj.160744</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Udell JA, Lu H, Redelmeier DA. Failure of fertility therapy and subsequent adverse cardiovascular events. Can Med Assoc J. 2017;189(10):391–397. doi:10.1503/cmaj.160744</mixed-citation><mixed-citation xml:lang="en">Udell JA, Lu H, Redelmeier DA. Failure of fertility therapy and subsequent adverse cardiovascular events. Can Med Assoc J. 2017;189(10):391–397. doi:10.1503/cmaj.160744</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Rogoza AN, Nikolsky VP, Oschepkova EV. Daily monitoring of blood pressure in hypertension. Methodical issues. Ed. by GG Arabidze and OYu Atkova. M.: Russian Cardiological Research and Production Complex of the Ministry of Health of the Russian Federation, 2005. 36 p. In Russian.</mixed-citation><mixed-citation xml:lang="en">Rogoza AN, Nikolsky VP, Oschepkova EV. Daily monitoring of blood pressure in hypertension. Methodical issues. Ed. by GG Arabidze and OYu Atkova. M.: Russian Cardiological Research and Production Complex of the Ministry of Health of the Russian Federation, 2005. 36 p. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Rogoza AN, Nikolsky VP, Oschepkova EV. Daily monitoring of blood pressure in hypertension. Methodical issues. Ed. by GG Arabidze and OYu Atkova. M.: Russian Cardiological Research and Production Complex of the Ministry of Health of the Russian Federation, 2005. 36 p. In Russian.</mixed-citation><mixed-citation xml:lang="en">Rogoza AN, Nikolsky VP, Oschepkova EV. Daily monitoring of blood pressure in hypertension. Methodical issues. Ed. by GG Arabidze and OYu Atkova. M.: Russian Cardiological Research and Production Complex of the Ministry of Health of the Russian Federation, 2005. 36 p. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Rus J Cardiol. 2018;23(12):143–228. In Russian.</mixed-citation><mixed-citation xml:lang="en">The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Rus J Cardiol. 2018;23(12):143–228. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Rus J Cardiol. 2018;23(12):143–228. In Russian.</mixed-citation><mixed-citation xml:lang="en">The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Rus J Cardiol. 2018;23(12):143–228. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Imudia AN, Awonuga AO, Doyle JO, Kaimal AJ, Wright DL, Toth TL et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril. 2012;97(6):1374–1379.</mixed-citation><mixed-citation xml:lang="en">Imudia AN, Awonuga AO, Doyle JO, Kaimal AJ, Wright DL, Toth TL et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril. 2012;97(6):1374–1379.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Imudia AN, Awonuga AO, Doyle JO, Kaimal AJ, Wright DL, Toth TL et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril. 2012;97(6):1374–1379.</mixed-citation><mixed-citation xml:lang="en">Imudia AN, Awonuga AO, Doyle JO, Kaimal AJ, Wright DL, Toth TL et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril. 2012;97(6):1374–1379.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Sun X, Zang L, Zhang Q, Li J, Zou S. Correlation between steroid hormonal levels and cardiac function in women during controlled ovarian hyperstimulation. Endocrine. 2013;44(3):784–789.</mixed-citation><mixed-citation xml:lang="en">Li Y, Sun X, Zang L, Zhang Q, Li J, Zou S. Correlation between steroid hormonal levels and cardiac function in women during controlled ovarian hyperstimulation. Endocrine. 2013;44(3):784–789.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Sun X, Zang L, Zhang Q, Li J, Zou S. Correlation between steroid hormonal levels and cardiac function in women during controlled ovarian hyperstimulation. Endocrine. 2013;44(3):784–789.</mixed-citation><mixed-citation xml:lang="en">Li Y, Sun X, Zang L, Zhang Q, Li J, Zou S. Correlation between steroid hormonal levels and cardiac function in women during controlled ovarian hyperstimulation. Endocrine. 2013;44(3):784–789.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002;53(3):688–708.</mixed-citation><mixed-citation xml:lang="en">Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002;53(3):688–708.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002;53(3):688–708.</mixed-citation><mixed-citation xml:lang="en">Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002;53(3):688–708.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Sealey JE, Itskovitz-Eldor J, Rubattu S, James GD, August. Estradiol and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab. 1994;79(1):258–264.</mixed-citation><mixed-citation xml:lang="en">Sealey JE, Itskovitz-Eldor J, Rubattu S, James GD, August. Estradiol and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab. 1994;79(1):258–264.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Sealey JE, Itskovitz-Eldor J, Rubattu S, James GD, August. Estradiol and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab. 1994;79(1):258–264.</mixed-citation><mixed-citation xml:lang="en">Sealey JE, Itskovitz-Eldor J, Rubattu S, James GD, August. Estradiol and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab. 1994;79(1):258–264.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Sealey JE, Itskovitz-Eldor J, Rubattu S, James GD, August. Estradiol and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab. 1994;79(1):258–264.</mixed-citation><mixed-citation xml:lang="en">Sealey JE, Itskovitz-Eldor J, Rubattu S, James GD, August. Estradiol and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab. 1994;79(1):258–264.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
